Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

NCT01605721 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: XIENCE PRIMETM everolimus-eluting coronary stent

Sponsor

Seoul National University Hospital

Collaborators

[object Object]